Decades of clinical research have consolidated the evidence that managing high risk acute coronary syndromes with an early invasive strategy — coronary angiography coupled with coronary revascularisation when appropriate — reduces cardiac mortality and the risk of recurrent myocardial infarction.1 Clinical trial evidence also supports coronary anatomic investigation of chest pain that suggests coronary artery disease (CAD), averting future myocardial infarction by facilitating initiation of preventive therapies.2 These insights provide the clinical rationale for coronary angiography.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.